The threefold increase in the PRKAG2 gene expression with raised AMPK levels is related to an increase in beta-amyloid accumulation in the brains of patients with Alzheimer’s disease [19]. Here, PRKAG2 is linked to early-onset autosomal dominant Alzheimer disease.